Cargando…

Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial

Detalles Bibliográficos
Autores principales: Packer, Milton, Zannad, Faiez, Butler, Javed, Filippatos, Gerasimos, Ferreira, Joao Pedro, Pocock, Stuart J., Brueckmann, Martina, Zeller, Cordula, Hauske, Sibylle, Anker, Stefan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291539/
https://www.ncbi.nlm.nih.gov/pubmed/34459076
http://dx.doi.org/10.1002/ejhf.2334
_version_ 1784749159076593664
author Packer, Milton
Zannad, Faiez
Butler, Javed
Filippatos, Gerasimos
Ferreira, Joao Pedro
Pocock, Stuart J.
Brueckmann, Martina
Zeller, Cordula
Hauske, Sibylle
Anker, Stefan D.
author_facet Packer, Milton
Zannad, Faiez
Butler, Javed
Filippatos, Gerasimos
Ferreira, Joao Pedro
Pocock, Stuart J.
Brueckmann, Martina
Zeller, Cordula
Hauske, Sibylle
Anker, Stefan D.
author_sort Packer, Milton
collection PubMed
description
format Online
Article
Text
id pubmed-9291539
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Ltd.
record_format MEDLINE/PubMed
spelling pubmed-92915392022-07-20 Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial Packer, Milton Zannad, Faiez Butler, Javed Filippatos, Gerasimos Ferreira, Joao Pedro Pocock, Stuart J. Brueckmann, Martina Zeller, Cordula Hauske, Sibylle Anker, Stefan D. Eur J Heart Fail Research Letter John Wiley & Sons, Ltd. 2021-08-30 2021-10 /pmc/articles/PMC9291539/ /pubmed/34459076 http://dx.doi.org/10.1002/ejhf.2334 Text en © 2021 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Letter
Packer, Milton
Zannad, Faiez
Butler, Javed
Filippatos, Gerasimos
Ferreira, Joao Pedro
Pocock, Stuart J.
Brueckmann, Martina
Zeller, Cordula
Hauske, Sibylle
Anker, Stefan D.
Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial
title Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial
title_full Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial
title_fullStr Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial
title_full_unstemmed Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial
title_short Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial
title_sort influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the emperor‐preserved trial
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291539/
https://www.ncbi.nlm.nih.gov/pubmed/34459076
http://dx.doi.org/10.1002/ejhf.2334
work_keys_str_mv AT packermilton influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial
AT zannadfaiez influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial
AT butlerjaved influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial
AT filippatosgerasimos influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial
AT ferreirajoaopedro influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial
AT pocockstuartj influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial
AT brueckmannmartina influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial
AT zellercordula influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial
AT hauskesibylle influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial
AT ankerstefand influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial
AT influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial